Chemistry Interdisciplinary Project (CHIP), School of Science and Technology, University of Camerino, via Madonna delle Carceri, 62032 Camerino, Macerata, Italy.
Chemistry Interdisciplinary Project (CHIP), School of Pharmacy, University of Camerino, via Madonna delle Carceri, 62032 Camerino, Macerata, Italy.
Inorg Chem. 2022 Aug 29;61(34):13561-13575. doi: 10.1021/acs.inorgchem.2c02201. Epub 2022 Aug 15.
Two pyrazolone-based hydrazones HL' [in general, HL'; in detail, = 5-methyl-2-phenyl-4-(2-phenyl-1-(2-(4-(trifluoromethyl)phenyl)hydrazineyl)ethyl)-2,4-dihydro-3-pyrazol-3-one, = ()-5-methyl-2-phenyl-4-(2-phenyl-1-(2-(pyridin-2-yl)hydrazineyl)ethylidene)-2,4-dihydro-3-pyrazol-3-one] were reacted with Zn(II) and Cu(II) acceptors affording the complexes [Zn(HL)(MeOH)], [Cu(HL)], and [M(HL)] (M = Cu or Zn). X-ray and DFT studies showed the free proligands to exist in the N-H,N-H tautomeric form and that in [Zn(HL)(MeOH)], zinc is six-coordinated by the N,O-chelated (HL) ligand and other two oxygen atoms of coordinated methanol molecules, while [Cu(HL)] adopts a square planar geometry with the two (HL) ligands in anti-conformation. Finally, the [M(HL)] complexes are octahedral with the two (HL) ligands acting as κ-O,N,N-donors in planar conformation. Both the proligands and metal complexes were tested against the parasite and Balb3T3 cells. The Zn(II) complexes were found to be very powerful, more than the starting proligands, while maintaining a good safety level. In detail, and its Zn(II) complex have high selective index (55 and >100, respectively) against compared to the mammalian Balb/3T3 reference cells. These results encouraged the researchers to investigate the mechanism of action of these compounds that have no structural relations with the already known drugs used against . Interestingly, the analysis of NTP and dNTP pools in treated by and its Zn(II) complex showed that the drugs had a strong impact on the CTP pools, making it likely that CTP synthetase is the targeted enzyme.
两个基于吡唑啉酮的腙 HL'(一般情况下,HL';详细情况下,HL'=5-甲基-2-苯基-4-(2-苯基-1-(2-(4-(三氟甲基)苯基)腙基)乙基)-2,4-二氢-3-吡唑-3-酮,HL'=()-5-甲基-2-苯基-4-(2-苯基-1-(2-(吡啶-2-基)腙基)亚乙基)-2,4-二氢-3-吡唑-3-酮)与 Zn(II)和 Cu(II)受体反应,生成配合物[Zn(HL)(MeOH)]、[Cu(HL)]和[M(HL)](M=Cu 或 Zn)。X 射线和 DFT 研究表明,游离前体以 N-H,N-H 互变异构形式存在,在[Zn(HL)(MeOH)]中,锌由 N,O-螯合(HL)配体和配位甲醇分子的另外两个氧原子六配位,而[Cu(HL)]采用反式构象的平面四方几何形状。最后,[M(HL)]配合物为八面体构型,两个(HL)配体以平面构型作为 κ-O,N,N-供体。前体和金属配合物都针对寄生虫和 Balb3T3 细胞进行了测试。发现 Zn(II)配合物非常有效,比起始前体更有效,同时保持良好的安全性水平。具体而言,与哺乳动物 Balb/3T3 参考细胞相比,和其 Zn(II)配合物对有很高的选择性指数(分别为 55 和>100)。这些结果促使研究人员研究这些化合物的作用机制,这些化合物与已经用于治疗的药物没有结构关系。有趣的是,对用和其 Zn(II)配合物处理的 CTP 池和 dNTP 池的分析表明,这些药物对 CTP 池有很强的影响,这使得 CTP 合成酶很可能是靶酶。